{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:22:13Z","timestamp":1782030133775,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jhep.2014.02.013","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T04:31:10Z","timestamp":1393389070000},"page":"1127-1134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation"],"prefix":"10.1016","volume":"60","author":[{"given":"Chien-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Lang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Lin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Houng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Mo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.02.013_b0005","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection","volume":"337","author":"Lee","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.02.013_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.8211155","article-title":"From hepatitis to hepatoma: lessons from type B viral hepatitis","volume":"262","author":"Chen","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.02.013_b0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1478-3231.2008.01941.x","article-title":"Natural history of chronic hepatitis B virus infection and long-term outcome under treatment","volume":"29","author":"Liaw","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.02.013_b0020","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1143::AID-CNCR7>3.0.CO;2-Z","article-title":"Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection","volume":"86","author":"Lee","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2014.02.013_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0168-8278(90)90069-4","article-title":"Acute exacerbation in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology","volume":"10","author":"Lok","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1440-1746.2009.05924.x","article-title":"Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease","volume":"24","author":"Wong","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","author":"Liaw","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2014.02.013_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one-year trial of lamivudine for chronic hepatitis B","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.02.013_b0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0168-8278(02)00267-2","article-title":"Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation","volume":"37","author":"Lee","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0050","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.02.013_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2014.02.013_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.02.013_b0065","first-page":"167","article-title":"Management of chronic hepatitis B virus infection","volume":"57","author":"EASL Clinical Practice Guidelines","year":"2012","journal-title":"Eur Assoc Study Liver J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/135965350601100404","article-title":"Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B","volume":"11","author":"Chan","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2014.02.013_b0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/135965350801300407","article-title":"Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B","volume":"13","author":"Wong","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2014.02.013_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000080877","article-title":"Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection","volume":"47","author":"Tsubota","year":"2004","journal-title":"Intervirology"},{"key":"10.1016\/j.jhep.2014.02.013_b0085","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.02.013_b0090","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2007.08.025","article-title":"Entecavir therapy for up to 96weeks in patients with HBeAg-positive chronic hepatitis B","volume":"33","author":"Gish","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.02.013_b0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.23327","article-title":"Entecavir treatment for up to 5years in patients with hepatitis B e antigen\u2013positive chronic hepatitis B","volume":"51","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.02.013_b0100","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5years of therapy","volume":"49","author":"Tenney","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.02.013_b0105","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23346","article-title":"Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function","volume":"50","author":"Lange","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.02.013_b0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2010.06.043","article-title":"Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B","volume":"54","author":"Wong","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3851\/IMP2027","article-title":"Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation","volume":"17","author":"Hsu","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2014.02.013_b0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0168-8278(02)00419-1","article-title":"The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B","volume":"38","author":"Chien","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0125","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0016-5085(85)90566-9","article-title":"Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis","volume":"89","author":"Sheen","year":"1985","journal-title":"Gasteroenterology"},{"key":"10.1016\/j.jhep.2014.02.013_b0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cgh.2010.02.023","article-title":"Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B","volume":"8","author":"Jeng","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2014.02.013_b0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jhep.2004.04.032","article-title":"Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants","volume":"41","author":"Chen","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0145","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2007.09.002","article-title":"Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients","volume":"133","author":"Chen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.02.013_b0150","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1128\/JCM.43.12.6000-6006.2005","article-title":"Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan","volume":"43","author":"Chen","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2014.02.013_b0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jhep.2005.08.022","article-title":"Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy","volume":"44","author":"Chen","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1478-3231.2007.01505.x","article-title":"Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study","volume":"27","author":"Chen","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.02.013_b0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00365521.2018.12027892","article-title":"Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan","volume":"1","author":"Lee","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.02.013_b0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-011-0160-7","article-title":"Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"12","author":"Chen","year":"2012","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jhep.2014.02.013_b0175","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10620-010-1257-7","article-title":"Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure","volume":"55","author":"Cui","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2014.02.013_b0180","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate vs. adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.02.013_b0185","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.02.013_b0190","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/374226","article-title":"Prognostic factors in severe exacerbation of chronic hepatitis B","volume":"36","author":"Yuen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2014.02.013_b0195","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","article-title":"Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure","volume":"25","author":"Sun","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.02.013_b0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2893.2005.00608.x","article-title":"Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis","volume":"12","author":"Tseng","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.02.013_b0205","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/gut.52.11.1630","article-title":"Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan","volume":"52","author":"Imamura","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.02.013_b0210","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.510300313","article-title":"Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group","volume":"30","author":"Chien","year":"1999","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T19:30:16Z","timestamp":1689017416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0168827814001196"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.02.013","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.03.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}